NCT02596945

Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis

Non-Interventional Observation Trial to Investigate the Efficacy, Safety and Usability of Mircera in PD Patients in Daily Use

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 223 (actual)
• Sponsor: Hoffmann-La Roche · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This non-interventional, observational study investigates the efficacy, safety and usability of methoxy polyethylene glycol epoetin beta in participants on peritoneal dialysis. Participants who were prescribed methoxy polyethylene glycol epoetin beta by their doctor and who meet the selection criteria were to be enrolled and documented in this study for a period of 9 months of treatment with methoxy polyethylene glycol epoetin beta with respect to efficacy, safety and usability.

Conditions

• Renal Impairment
• Renal Anemia of Chronic Kidney Disease

Interventions

Type	Name	Description
DRUG	Methoxy polyethylene glycol epoetin beta	Methoxy polyethylene glycol epoetin beta is prescribed as per physician's discretion in accordance with the Summary of Product Characteristics (SmPC).

Timeline

• Start date: 2009-07-31
• Primary completion: 2011-02-28
• Completion: 2011-02-28
• First posted: 2015-11-04
• Last updated: 2017-07-02
• Results posted: 2016-01-13

Locations

1 site across 1 country: Germany